Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50000 participants
OBSERVATIONAL
2022-01-21
2027-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Cohort Study of Coronary Heart Disease
NCT00745628
Correlation of Biomarkers With the Presence and Severity of Coronary Artery Disease
NCT05015270
Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease
NCT05337319
Retrospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital
NCT02667028
Clinical Outcomes of Patients With Coronary Artery Disease
NCT06216847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects.
Exclusion Criteria
* Won't sign an inform consent.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jinan Central Hospital
OTHER
Shandong Provincial Hospital
OTHER_GOV
The Second Affiliated Hospital of Shandong First Medical University
OTHER
Qianfoshan Hospital
OTHER
Shandong First Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tao Xu, Dr.
Role: STUDY_CHAIR
Shandong First Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shandong First Medical University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rong Huang, Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-206-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.